ERBB2 and central nervous system cancer: The vaccine was pulsed with class I peptides from six tumour-associated antigens (TAA) of AIM-2, MAGE1, TRP-2, gp100, HER2/neu and IL-13Rα2, which are expressed on gliomas and over expressed in their cancer stem cell population.